Logo-hpp
2025: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2025):5.1
 
Platinum
Open Access

Health Promot Perspect. 2019;9(2): 92-98. doi: 10.15171/hpp.2019.13
PMID: 31249795        PMCID: PMC6588804

Systematic Review

A systematic review and meta-analysis on incidence of prostate cancer in Iran

Asaad Moradi 1, Mohammad Zamani 2,3 ORCID, Emadoddin Moudi 4,5 * ORCID

Cited by CrossRef: 7


1- Mahmoudi-zadeh M, Jalilpiran Y, Maghsoudi Z, Nouri M, Faghih S. The association between ultra-processed foods intake and the odds of prostate cancer: a case–control study. J Health Popul Nutr. 2025;44(1) [Crossref]
2- Shamsi M, Mirzaei M, Vaziri S, Mozaffari H. Common mistakes in reporting systematic reviews and meta-analyses. Health Promot Perspect. 2020;10(2):97 [Crossref]
3- Ramezankhani A, Razaghi M, Kavousi A, Marashi T, Moradi A. Designing, psychometric, and application of measurement instrument for Self-Care Literacy in Prevention of Prostate Cancer (SCL-PCa): A mixed-method study protocol. 2026;15(1) [Crossref]
4- EyvaziNasab K, Alimohammadi A, Almasi-Hashiani A. Incidence Trend of Prostate Cancer in Markazi Province (Center of Iran), Results of Population-based Cancer Registry, and Application of Joinpoint Regression Model, 2012-2017. TOPHJ. 2023;16(1) [Crossref]
5- Rezaee M, Karimzadeh I, Hashemi-Meshkini A, Zeighami S, Bazyar M, Lotfi F, Keshavarz K. Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective. Value in Health Regional Issues. 2024;42:100982 [Crossref]
6- Mehranfar S, Jalilpiran Y, Rahimi H, Jafari A, Setayesh L, Clark C, Faghih S. The association between dietary acid load and odds of prostate cancer: a case-control study. J Health Popul Nutr. 2025;44(1) [Crossref]
7- Mohiuddin A. Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1). 2019;1(2):17 [Crossref]
8- Askari S, Gholamiveis R, Safari-Faramani R. Subnational trends and provincial disparities in mortality-to-incidence ratios for six major cancers in Iran, 1990–2019. Cancer Epidemiology. 2026;104:103193 [Crossref]
9- Emamian A, Fateh M, Kordi Z, Enayatrad M, Emamian M. Thirteen year population based registry study of prostate cancer incidence and trend in Shahroud Iran using Joinpoint regression. Sci Rep. 2026;16(1) [Crossref]
10- Khani Jeihooni A, Amirkhani M, Mirshekari H, Kashfi S. Prostate Cancer Screening Behaviors Based on the Health Belief Model in Men Aged 40-70 Years in Fasa City, Fars Province, Iran, in 2019. PCNM. 2021;11(3):18 [Crossref]
11- Abbasi H, Ujjan I, Shaikh M, Kumari S, Sibghatullah H, Memon M. Deciphering the Diagnostic Potential of α-Methylacyl CoA Racemase (AMACR) in Prostatic Neoplasms. PJHS-Lahore. 2025;:64 [Crossref]
12- Bahari G, Rahimi N, Taheri M, Shahraki Ghadimi H, Hashemi M, Mohammadi S, Siri M, Narouie B. Variations of pre-miR-938, pre-miR-618, HOXA11-AS, and HULC genes and the risk of prostate cancer in an Iranian population: A case-control study with in-silico analysis. Sage Open Medicine. 2026;14 [Crossref]
13- Rasouli M, Moradi G, Zareie B, Sofimajidpour H, Tozandehjani S, Zafari H, Gholami F, Shahsavari S, Hassani P, Mohammadian M. Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018). BMC Cancer. 2021;21(1) [Crossref]
14- Mercola D. Obesity-linked genes may promote prostate cancer among Asian and Hispanic immigrants to North America. Front Public Health. 2026;14 [Crossref]
15- Darbandi M, Khorrami Z, Karamoozian A, Aboubakri O, Miryan M, Rezakhani L, Shadmani F, Hosseini Farash B. A comparison of the burden of cancers between 1990 and 2019 in Iran: A national and subnational study. PLoS ONE. 2025;20(2):e0309699 [Crossref]
16- Nowroozi M, Farkhani E, Hushmandi K, Amini E, Momeni S, Inanloo S, Bokaie S, Sharifi L. Trends in Incidence of Prostate Cancer in Iran and Its 31 Provinces During 2003 - 2016. Int J Cancer Manag. 2023;In Press(In Press) [Crossref]
17- Tajik M, Salehi S, Nasrollah S. Relationship between illness perception and quality of life in prostate cancer survivors. J Transl Med Res. 2026;33(1):62 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4

SCOPUS CiteScore: 5.1

  Scimago Journal & Country Rank 

 


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission